BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37795541)

  • 21. Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma.
    Gerami P; Geraminegad P
    G Ital Dermatol Venereol; 2010 Feb; 145(1):29-35. PubMed ID: 20197743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
    Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
    J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue.
    Koh SS; Opel ML; Wei JP; Yau K; Shah R; Gorre ME; Whitman E; Shitabata PK; Tao Y; Cochran AJ; Abrishami P; Binder SW
    Mod Pathol; 2009 Apr; 22(4):538-46. PubMed ID: 19270649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
    Bauer J; Bastian BC
    Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digital polymerase chain reaction for detecting c-MYC copy number gain in tissue and cell-free plasma samples of colorectal cancer patients.
    Lee KS; Nam SK; Seo SH; Park KU; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
    Sci Rep; 2019 Feb; 9(1):1611. PubMed ID: 30733532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases.
    North JP; Garrido MC; Kolaitis NA; LeBoit PE; McCalmont TH; Bastian BC
    Am J Surg Pathol; 2014 Jun; 38(6):824-31. PubMed ID: 24618603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What's new in prognostication of melanoma in the dermatopathology laboratory?
    Bangash HK; Romegialli A; Dadras SS
    Clin Dermatol; 2013; 31(3):317-23. PubMed ID: 23608451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
    Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
    Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors.
    Zaremba A; Jansen P; Murali R; Mayakonda A; Riedel A; Philip M; Rose C; Schaller J; Müller H; Kutzner H; Möller I; Stadtler N; Kretz J; Sucker A; Bankfalvi A; Livingstone E; Zimmer L; Horn S; Paschen A; Plass C; Schadendorf D; Hadaschik E; Lutsik P; Griewank K
    Int J Cancer; 2022 Nov; 151(9):1542-1554. PubMed ID: 35737508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescence in situ hybridization for ambiguous melanocytic tumors.
    Gammon B; Gerami P
    Histol Histopathol; 2012 Dec; 27(12):1539-42. PubMed ID: 23059884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spitzoid tumors in children and adults: a comparative clinical, pathological, and cytogenetic analysis.
    Dika E; Fanti PA; Fiorentino M; Capizzi E; Neri I; Piraccini BM; Ravaioli GM; Misciali C; Passarini B; Patrizi A
    Melanoma Res; 2015 Aug; 25(4):295-301. PubMed ID: 25933206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions.
    Minca EC; Al-Rohil RN; Wang M; Harms PW; Ko JS; Collie AM; Kovalyshyn I; Prieto VG; Tetzlaff MT; Billings SD; Andea AA
    Mod Pathol; 2016 Aug; 29(8):832-43. PubMed ID: 27174586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FISH analysis for diagnostic evaluation of challenging melanocytic lesions.
    Zimmermann AK; Hirschmann A; Pfeiffer D; Paredes BE; Diebold J
    Histol Histopathol; 2010 Sep; 25(9):1139-47. PubMed ID: 20607656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Busam KJ
    Am J Surg Pathol; 2020 Jul; 44(7):893-900. PubMed ID: 32317605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
    Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
    J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma.
    Gerami P; Jewell SS; Morrison LE; Blondin B; Schulz J; Ruffalo T; Matushek P; Legator M; Jacobson K; Dalton SR; Charzan S; Kolaitis NA; Guitart J; Lertsbarapa T; Boone S; LeBoit PE; Bastian BC
    Am J Surg Pathol; 2009 Aug; 33(8):1146-56. PubMed ID: 19561450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.
    Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P
    Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens.
    Abásolo A; Vargas MT; Ríos-Martín JJ; Trigo I; Arjona A; González-Cámpora R
    Clin Exp Dermatol; 2012 Dec; 37(8):838-43. PubMed ID: 22731835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
    Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
    Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.